Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza Versus Lyxumia as Add-on to Metformin in Type 2 Diabetes
NCT01973231Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Oct 2013
- Primary completion
- Nov 2014
- Countries
- 9
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Oct 2013; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01973231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01973231.